Yuval Harry - 22 Mar 2024 Form 4 Insider Report for Hippo Holdings Inc. (HIPO)

Role
Chief Revenue Officer
Signature
/s /Stewart Ellis, Attorney-in-Fact for Yuval Harry
Issuer symbol
HIPO
Transactions as of
22 Mar 2024
Net transactions value
-$171,793
Form type
4
Filing time
26 Mar 2024, 16:10:49 UTC
Previous filing
06 Mar 2024
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIPO Common Stock Options Exercise $32,768 +3,855 +2.6% $8.50 150,769 22 Mar 2024 Direct
transaction HIPO Common Stock Options Exercise $28,330 +3,333 +2.2% $8.50 154,102 22 Mar 2024 Direct
transaction HIPO Common Stock Options Exercise $23,992 +5,998 +3.9% $4.00 160,100 22 Mar 2024 Direct
transaction HIPO Common Stock Sale $30,223 -1,752 -1.1% $17.25 158,348 22 Mar 2024 Direct F1
transaction HIPO Common Stock Sale $103,117 -5,998 -3.8% $17.19 152,350 22 Mar 2024 Direct F2
transaction HIPO Common Stock Sale $57,317 -3,333 -2.2% $17.20 149,017 22 Mar 2024 Direct F3
transaction HIPO Common Stock Sale $66,226 -3,855 -2.6% $17.18 145,162 22 Mar 2024 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -3,855 -100% $0.000000* 0 22 Mar 2024 Common Stock 3,855 $8.50 Direct F6
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -3,333 -100% $0.000000* 0 22 Mar 2024 Common Stock 3,333 $8.50 Direct F7
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -5,998 -100% $0.000000* 0 22 Mar 2024 Common Stock 5,998 $4.00 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price.
F2 This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price.
F3 This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
F4 This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
F5 Includes 94,719 RSUs.
F6 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023.
F7 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023.
F8 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022.